New MRI technique could sharpen radiation for deadly brain tumors

NCT ID NCT05500612

Recruiting now Knowledge-focused Sponsor: University of Sydney Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether special MRI scans can identify low-oxygen (hypoxic) areas in glioblastoma, an aggressive brain cancer. Researchers will compare these scans with a standard PET imaging method in 20 participants. The goal is to see if MRI can reliably guide radiation therapy to the most dangerous parts of the tumor, potentially making treatment more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more targeted radiation therapy for glioblastoma, potentially improving treatment outcomes.
What could go wrong: This is a very small early-stage study (20 participants) focused on imaging, not treatment. It may not lead to direct patient benefits or change clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma glioma susceptibility 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA MULTIFORME

Contacts and locations

Locations

North Shore Private Hospital
NOT_YET_RECRUITING

St Leonards, New South Wales, 2065, Australia
Royal North Shore Hospital
RECRUITING

St Leonards, New South Wales, 2065, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.